Basic Materials / Specialty ChemicalsAmsterdam
$66.04
+0.38 (+0.58%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 23%
FCF escenarios
weak_data · normalized FCF $606.0M · quality 53.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
55/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$11.3B
P/E
18.2x
↑EV/EBITDA
9.2x
↓ROE
13.6%
↑Gross Margin
39.9%
↑Debt/Equity
1.04
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-2.2%
FCF CAGR
—
FCF margin
6.0%
FCF / Net income
0.95x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $10.16B · net income $635.0M · FCF $606.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $10.16B | $10.16B | $10.71B | $10.67B | $10.85B |
| Net Income | $635.0M | $635.0M | $542.0M | $442.0M | $352.0M |
| EBITDA | $1.59B | $1.59B | $1.40B | $1.33B | $1.08B |
| EPS | 3.69 | 3.69 | 3.16 | 2.58 | 2.01 |
| Gross Margin | 39.9% | 39.9% | 40.5% | 39.7% | 36.2% |
| Operating Margin | 11.5% | 11.5% | 8.6% | 9.6% | 6.5% |
| Net Margin | 6.3% | 6.3% | 5.1% | 4.1% | 3.2% |
| Balance Sheet | |||||
| Debt/Equity | 1.04 | 1.04 | 1.17 | 1.29 | 1.36 |
| Current Ratio | 1.72 | 1.72 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $606.0M | $606.0M | $367.0M | $840.0M | $-29.0M |
| Returns | |||||
| ROE | 13.6% | 13.6% | 11.8% | 10.2% | 8.1% |
| Valuation | |||||
| P/E | 18.24 | 18.24 | 17.72 | 27.44 | 32.49 |
| EV/EBITDA | 9.20 | 9.20 | 9.77 | 12.13 | 14.75 |
| P/B | 2.44 | 2.44 | 2.10 | 2.81 | 2.64 |
| Growth & Yield | |||||
| Revenue Growth | -5.2% | -5.2% | 0.4% | -1.6% | — |
| EPS Growth | 16.8% | 16.8% | 22.5% | 28.4% | — |
| Dividend Yield | 3.0% | 3.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
16.7%
EPS terminal req.
$5.86
Spread vs growth
0.1%
5Y implied EPS CAGR
14.0%
EPS terminal req.
$7.09
Spread vs growth
2.8%
10Y implied EPS CAGR
12.0%
EPS terminal req.
$11.42
Spread vs growth
4.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+15.9%
Start / end P/E
18.5x → 17.9x
EPS bridge
3.16 → 3.69
Residual
-0.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.